The gap between trailing and forward P/E suggests investors are paying for an anticipated recovery in operating income rather than current earnings. The PEG of 1.37 is reasonable only if the revenue reacceleration seen in 2026Q3 proves durable, which the volatile margin history does not yet confirm. Investors should monitor whether the forward multiple compresses as acquired operations are integrated.

The jump in leverage tracks the acquisition-funded balance sheet expansion rather than organic deleveraging, which changes the risk profile of the equity. Interest coverage remains above conventional stress thresholds, but the direction of travel warrants further investigation given the 16.4% operating margin in the same quarter. Debt-to-EBITDA of 10.62 is elevated relative to the 4 to 6 range of the prior nine quarters.

With goodwill reaching $1.0B against net PP&E of $355.8M, the denominator of invested capital has expanded faster than operating profit. The return compression is therefore largely a capital allocation effect rather than a pure operating deterioration. Whether ROIC recovers toward its prior band depends on integration outcomes that remain unresolved in the reported data.

The headline liquidity ratios are supported more by receivables and inventory than by cash on hand, which makes working capital quality the key determinant of near-term flexibility. Inventory dependence is moderate with DIO of 113 days in 2026Q3. Under a severe demand shock, the position would likely rely on collection speed and revolver availability, neither of which is fully visible in the supplied data.